Progress and Potential of Imaging Mass Spectrometry Applied to Biomarker Discovery

Methods in Molecular Biology
Jusal QuanicoIsabelle Fournier

Abstract

Mapping provides a direct means to assess the impact of protein biomarkers and puts into context their relevance in the type of cancer being examined. To this end, mass spectrometry imaging (MSI) was developed to provide the needed spatial information which is missing in traditional liquid-based mass spectrometric proteomics approaches. Aptly described as a "molecular histology" technique, MSI gives an additional dimension in characterizing tumor biopsies, allowing for mapping of hundreds of molecules in a single analysis. A decade of developments focused on improving and standardizing MSI so that the technique can be translated into the clinical setting. This review describes the progress made in addressing the technological development that allows to bridge local protein detection by MSI to its identification and to illustrate its potential in studying various aspects of cancer biomarker discovery.

Citations

Nov 4, 2020·Rapid Communications in Mass Spectrometry : RCM· BurenbatuHaihua Bai
Apr 28, 2018·Biochimica Et Biophysica Acta. Reviews on Cancer·Akash K Kaushik, Ralph J DeBerardinis
Aug 3, 2018·Analytical Chemistry·Khalil MallahIsabelle Fournier
Aug 28, 2021·Analytical Chemistry·Lauranne DrelichMaxence Wisztorski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.